ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000

In Brief: ACS Awards Professorship To Bernstein; HCFA Clears Dana-Farber For Medicare

August 11, 1995

NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2

November 23, 1990

Conferees Set NIH Funding At $30 Billion.

November 2, 2007

House Labor-HHS-Ed/ Committee Concerned About Cut In Prevention, Construction Budget

March 20, 1992